Developing new smallpox vaccines

Emerging Infectious Diseases

Volumn 7, Issue 6, 2001, Pages 920-926

  Rosenthal, Steven R ^a   Merchlinsky, Michael ^a   Kleppinger, Cynthia ^a   Goldenthal, Karen L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN; LC16M8; LIVE VACCINE; MODIFIED VACCINIA ANKARA; RUBELLA VACCINE; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VACCINIA ANTIBODY;

BIOLOGICAL WARFARE; CATTLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG LEGISLATION; DRUG SAFETY; DRUG SYNTHESIS; ECZEMA; GOVERNMENT; HIGH RISK POPULATION; HUMAN; LYMPH; NEUROLOGIC DISEASE; PROTECTION; REVIEW; SKIN DISEASE; SMALLPOX; SOLDIER; STEVENS JOHNSON SYNDROME; STRAIN DIFFERENCE; VACCINE PRODUCTION; VACCINIA VIRUS; VIROGENESIS; VIRUS TRANSMISSION;

EID: 0035194006     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0706.010602     Document Type: Review

References (59)

1. The looming threat of bioterrorism
2. Smallpox: Clinical and epidemiologic features
3. Government report says 3 nations hide stocks of smallpox
4. Poxvirus dilemmas - Monkeypox, smallpox, and biologic terrorism
5. Modeling potential responses to smallpox as a bioterrorist weapon
6. The demon in the freezer
7. Smallpox vaccine no longer available for civilians - United States
8. Immunologic responses to vaccinia vaccines administered by different parenteral routes
9. Laboratory and vaccination studies with dried smallpox vaccines
10. Smallpox vaccination studies with serial dilutions of vaccine
11. Smallpox vaccination revisited: Some observations on the biology of vaccinia
12. Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA
13. Complications of vaccination against smallpox
14. Complications of smallpox vaccination - United States, 1963. II. Results obtained by four statewide surveys
15. Complications of smallpox vaccination. I. National survey in the United States, 1963
16. Complications of smallpox vaccination: 1968 Surveillance in a comprehensive care clinic
17. Routine childhood vaccination against smallpox reconsidered
18. Complications of smallpox vaccination, 1968
19. Complications of smallpox vaccination, 1968: Results of ten statewide surveys
20. Progressive vaccinia in immunologically deficient individuals
21. Eczema vaccinatum
22. Acute pericarditis after smallpox vaccination
23. Postvaccination arthritis
24. Malignant tumors in smallpox vaccination scars
25. Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968
26. Contact spread of vaccinia from a recently vaccinated Marine - Louisiana
27. Contact spread of vaccinia from a National Guard vaccinee - Wisconsin
28. Vaccinia outbreak - Newfoundland
29. Vaccinia outbreak - Nevada
30. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease
31. Vero cell standardized tests for adventitious agents urged by FDA panel
32. Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines
33. Smallpox vaccination in Japan
34. Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus
35. Assay development. Assay validation
36. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; final rule
37. Postmarketing studies for approved human drug and licensed biological products; status reports
38. Recommendations of the immunization practices advisory committee (ACIP) vaccinia (smallpox) vaccine
39. The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox
40. Prophylactic effect on antivaccinia gamma-globulin against post-vaccinal encephalitis
41. Illness attributed to smallpox vaccination during 1951-60
42. Hyperimmune vaccinal gamma globulin
43. Complications of smallpox vaccination. Effects of vaccinia immune globulin therapy
44. Experience of anti-vaccinia immunoglobulin in the United Kingdom
45. Smallpox vaccination reactions, prophylaxis, and therapy of complications
46. The efficacy of vaccinial immune globulin. A 15-year study
47. Therapy of experimental vaccinal keratitis. Effect of idoxuridine and VIG
48. Treatment of eczema vaccinatum with N-methylisatin beta-thiosemicarbazone
49. Methisazone in prevention of variola minor among contacts
50. Adverse reactions to smallpox vaccination - 1978
51. New drug and biological drug products: Evidence needed to demonstrate efficacy of new drugs for use against lethal or permanently disabling toxic substances when efficacy studies in humans ethically cannot be conducted
52. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge